X-48600589-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BP4BS2
The NM_001347217.2(WDR13):āc.794G>Cā(p.Cys265Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000579 in 1,209,564 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 22 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00033 ( 0 hom., 13 hem., cov: 25)
Exomes š: 0.000030 ( 0 hom. 9 hem. )
Consequence
WDR13
NM_001347217.2 missense
NM_001347217.2 missense
Scores
2
3
11
Clinical Significance
Conservation
PhyloP100: 8.73
Genes affected
WDR13 (HGNC:14352): (WD repeat domain 13) This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by Gly-His and Trp-Asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. A similar protein in mouse is thought to be a negative regulator of the pancreatic beta cell proliferation. Mice lacking this gene exhibit increased pancreatic islet mass and higher serum insulin levels, and are mildly obese. [provided by RefSeq, Nov 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), WDR13. . Gene score misZ 3.2948 (greater than the threshold 3.09). GenCC has associacion of gene with intellectual disability.
BP4
Computational evidence support a benign effect (MetaRNN=0.304806).
BS2
High Hemizygotes in GnomAd4 at 13 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WDR13 | NM_001347217.2 | c.794G>C | p.Cys265Ser | missense_variant | 6/10 | ENST00000376729.10 | NP_001334146.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WDR13 | ENST00000376729.10 | c.794G>C | p.Cys265Ser | missense_variant | 6/10 | 5 | NM_001347217.2 | ENSP00000365919 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000328 AC: 37AN: 112673Hom.: 0 Cov.: 25 AF XY: 0.000373 AC XY: 13AN XY: 34831
GnomAD3 genomes
AF:
AC:
37
AN:
112673
Hom.:
Cov.:
25
AF XY:
AC XY:
13
AN XY:
34831
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000391 AC: 7AN: 178981Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 63785
GnomAD3 exomes
AF:
AC:
7
AN:
178981
Hom.:
AF XY:
AC XY:
0
AN XY:
63785
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000301 AC: 33AN: 1096891Hom.: 0 Cov.: 31 AF XY: 0.0000248 AC XY: 9AN XY: 362323
GnomAD4 exome
AF:
AC:
33
AN:
1096891
Hom.:
Cov.:
31
AF XY:
AC XY:
9
AN XY:
362323
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000328 AC: 37AN: 112673Hom.: 0 Cov.: 25 AF XY: 0.000373 AC XY: 13AN XY: 34831
GnomAD4 genome
AF:
AC:
37
AN:
112673
Hom.:
Cov.:
25
AF XY:
AC XY:
13
AN XY:
34831
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
15
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 22, 2022 | The c.794G>C (p.C265S) alteration is located in exon 5 (coding exon 5) of the WDR13 gene. This alteration results from a G to C substitution at nucleotide position 794, causing the cysteine (C) at amino acid position 265 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;.;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;.;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;.
REVEL
Uncertain
Sift
Benign
T;T;.
Sift4G
Benign
T;T;T
Vest4
MutPred
Gain of disorder (P = 0.0138);Gain of disorder (P = 0.0138);.;
MVP
MPC
1.4
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at